The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Abstract
Background— Higher levels of serum phosphate are associated with adverse cardiovascular outcomes, especially in the setting of overt hyperphosphatemia. Given the biological importance of phosphorus, it is plausible that higher levels of serum phosphate within the normal range may also be associated with adverse outcomes. Methods and Results— We performed a post hoc analysis of data from the Cholesterol And Recurrent Events (CARE) study. Baseline serum phosphate levels were measured in 4127 fasting participants who were randomized to receive pravastatin 40 mg daily or placebo and followed up for a median of 59.7 months. We used Cox proportional-hazards models to examine the association between serum phosphate and adverse clinical outcomes after adjustment for potential confounders. During nearly 60 months of follow-up, 375 participants died. A significant association was noted between baseline serum phosphate level and the age-, race-, and sex-adjusted risk of all-cause death (hazard ratio per 1 mg/dL, 1.27; 95% confidence interval, 1.02 to 1.58). After categorization based on baseline phosphate level (<2.5, 2.5 to 3.4, 3.5 to 3.9, and ≥4 mg/dL) and further adjustment, a graded independent relation between phosphate and death was observed ( P for trend=0.03). For instance, participants with serum phosphate ≥3.5 mg/dL had an adjusted hazard ratio for death of 1.27 (95% confidence interval, 1.02 to 1.59) compared with those with serum phosphate of <3.5 mg/dL. Higher levels of serum phosphate were also associated with increased risk of new heart failure, myocardial infarction, and the composite of coronary death or nonfatal myocardial infarction, but not the risk of stroke. Conclusions— We found a graded independent relation between higher levels of serum phosphate and the risk of death and cardiovascular events in people with prior myocardial infarction, most of whom had serum phosphate levels within the normal range. Given the ready availability and low cost of serum phosphate assays, this finding may prove clinically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Self-citationMineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Rule, A. D., Larson, T. S., Bergstralh, E. J., Slezak, J. M., Jacobsen, S. J., & Cosio, F. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-12-200412210-00009 · Cited by 1,066
Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?
Zittermann, A., Schleithoff, S. S., Tenderich, G., Berthold, H. K., Körfer, R., & Stehle, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02624-4 · Cited by 536
Vascular calcification in chronic kidney disease
Goodman, W. G., London, G., Amann, K., Block, G. A., Giachelli, C., Hruska, K. A., Ketteler, M., Levin, A., Massy, Z., McCarron, D. A., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.005 · Cited by 417
Bostom, A. G., Kronenberg, F., & Ritz, E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022011.35035.f3 · Cited by 410
SCRAGG, R., JACKSON, R., HOLDAWAY, I. M., LIM, T., & BEAGLEHOLE, R. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.3.559 · Cited by 394
Bone Mass, Vitamin D Deficiency, and Hyperparathyroidism in Congestive Heart Failure
Shane, E., Mancini, D., Aaronson, K., Silverberg, S. J., Seibel, M. J., Addesso, V., & McMahon, D. J. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00142-3 · Cited by 358
Portale, A. A., Halloran, B. P., Murphy, M. M., & Morris, R. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112304 · Cited by 273
Portale, A. A., Halloran, B. P., & Morris, R. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114043 · Cited by 269
Adjusting Survival Curves for Confounders: A Review and a New Method
Nieto, F. J., & Coresh, J. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008670 · Cited by 216
de Boer, I. H., Gorodetskaya, I., Young, B., Hsu, C.-Y., & Chertow, G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034202.91413.eb · Cited by 181
Sacks, F. M., Pfeffer, M. A., Moyé, L. A., Brown, L. E., Hamm, P., Cole, T. G., HAWKINS, C. M., Braunwald, E., & The CARE Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90276-q · Cited by 125
Self-citationElevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency
Hsu, C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.8.1419 · Cited by 125
Consequences of Phosphate Imbalance
Berner, Y., & Shike, M. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.001005 · Cited by 117
Clinical and demographic predictors of exercise capacity in end-stage renal disease
Sietsema, K. E., Hiatt, W. R., Esler, A. L., Adler, S. G., Amato, A., & Brass, E. P. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29884 · Cited by 90
Vitamin D metabolism and mechanisms of calcium transport.
Kumar, R. (1990) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1130 · Cited by 55
Fluid and electrolyte disorders
Prata‐Barbosa, A., & Sztajnbok, J. (1999) · Jornal de Pediatria · doi:10.2223/jped.392 · Cited by 51
What have we learnt about the regulation of phosphate metabolism?
Blumsohn, A. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000133983.40182.c3 · Cited by 34
Low serum levels of intact osteocalcin in patients with congestive heart failure.
Schleithoff, S. S., Zittermann, A., Stüttgen, B., et al. (2003) · PubMed · doi:10.1007/s00774-003-0417-7 · Cited by 25
Calcification or Classification?
Chertow, G. M., & Moe, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121115 · Cited by 13
Cited by
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Shanahan, C. M., Crouthamel, M. H., Kapustin, A., & Giachelli, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234914 · Cited by 958
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Metadata
- Authors
- Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G.
- Venue
- Circulation
- Published
- 2005-10-25
- Volume
- 112
- Issue
- 17
- Pages
- 2627-2633
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2148134624
- Cited by
- 885
- References
- 27
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.